[Immunomodulators in the "gold standard" of the chronic viral hepatitis C therapy].

The best therapeutic effect in the treatment of patients with chronic virus hepatitis C was observed with the use of cycloferon included into the standard antiviral therapy with alpha-interferon and ribavirine. The 18-month observation revealed an increase of the biochemical and antiviral responses to 41.0 and 30.7% respectively. The use of cycloferon provided a decrease in the frequency and manifestation of the side effects. The therapy with the use of cycloferon had a favourable effect on the indices of the quality of life of the patients: by the majority of the scales of the questionnaires it was appraised maximum (from 85 to 96 points).